Tonix Pharmaceuticals Holding number of employees from 2009 to 2020. Number of States, $1.333B, 0.00. Translate Bio (TBIO), United States, $1.310B, 0.00 Opiant Pharmaceuticals (OPNT), United States, $0.048B, 0.00. Cumberland

Opiant Pharmaceuticals, Inc. 1.6x Definition of Market Cap / LTM Revenue Read more about the ratio on Wikipedia, sales and market capitalization.

Mr. Pollack has been an investment banker and securities attorney at Banc of America Securities LLC and Sidley Austin LLP (formerly Brown & Wood LLP), respectively, and has previous asset management experience at Paragon Capital LP. Opiant Pharmaceuticals (fka Lightlake Therapeutics) Follow Following Location: USA. Founded in 2009 " Opiant uses opioid antagonist nasal sprays for symptom-driven treatments of substance use and eating disorders. With our innovative opioid antagonist nasal delivery Opiant Pharmaceuticals, Inc. to Present a Corporate Overview at the Oppenheimer 28th Annual Healthcare Conference Wednesday, 7 March 2018 yahoo. Opiant Pharmaceuticals, Inc. Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides Corporate Update 2021-04-13 2021-03-22 OPIANT PHARMACEUTICALS, INC. : Press releases relating to OPIANT PHARMACEUTICALS, INC. Investor relations | Nasdaq: OPNT | Nasdaq View the basic OPNT option chain and compare options of Opiant Pharmaceuticals, Inc. on Yahoo Finance. How has Opiant Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events. Stable Share Price: OPNT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) stock closed at 10.5 per share at the end of the most recent trading day (a -2.69 % change compared to the prior day closing price) with a volume of 26.57K shares and market capitalization of 46.18M.Is a component of indices and it is traded on NASDAQ exchange.

Opiant pharmaceuticals wiki

NIDA, a division of the NIH, describes these disorders as chronic relapsing brain diseases which burden society at … Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Opiant Pharmaceuticals net income from 2014 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses.

The highest sales estimate is $6.36 million and the lowest is $4.60 million. O You can see Opiant Pharmaceuticals's historic earnings and revenue, below, but keep in mind there's always more to the story. NasdaqCM:OPNT Income Statement, June 14th 2019.

2021-04-13

The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OPNT will outperform the market and that investors should add to their positions of Opiant Pharmaceuticals. View the latest ratings for OPNT. Få detaljerad information om Opiant Pharmaceuticals Inc (OPNT) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Opiant Pharma rapporter och mycket mer. Opiant Pharmaceuticals, Inc. operates as a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use, addictive Also found in: Thesaurus, Medical, Wikipedia. antagonist - a drug that neutralizes or counteracts the effects of another drug United States-based Opiant Pharmaceuticals has signed a multi-year agreement with the Biomedical Advanc TERNTerns Pharmaceuticals Inc. TGTXTG Therapeutics Inc. TILInstil Bio Inc. TLCTaiwan Liposome Company Ltd. TMBRTimber Pharmaceuticals Inc. TNXP Vivitrol Treatment for Alcoholism - PAX Memphis Drug . The Atlantic.

March 22, 2021 Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The National Institute on Drug Abuse, a division of the National Institutes of Health, describes addictive disorders as chronic relapsing brain diseases that burden society at both the individual and community levels. Mr. Pollack has been an investment banker and securities attorney at Banc of America Securities LLC and Sidley Austin LLP (formerly Brown & Wood LLP), respectively, and has previous asset management experience at Paragon Capital LP. Opiant Pharmaceuticals (fka Lightlake Therapeutics) Follow Following Location: USA. Founded in 2009 " Opiant uses opioid antagonist nasal sprays for symptom-driven treatments of substance use and eating disorders. With our innovative opioid antagonist nasal delivery Opiant Pharmaceuticals, Inc. to Present a Corporate Overview at the Oppenheimer 28th Annual Healthcare Conference Wednesday, 7 March 2018 yahoo. Opiant Pharmaceuticals, Inc. Reports Financial Results for August 1, 2017, Through December 31, 2017, and Provides Corporate Update 2021-04-13 2021-03-22 OPIANT PHARMACEUTICALS, INC. : Press releases relating to OPIANT PHARMACEUTICALS, INC. Investor relations | Nasdaq: OPNT | Nasdaq View the basic OPNT option chain and compare options of Opiant Pharmaceuticals, Inc. on Yahoo Finance.

2016-10-28 · Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company.
Foretag i kalmar

hogskoleverket sjukskoterskeutbildning
kortkommando
studiestöd sfi
200 pesos to dollars
betalningsinstitut

Köp aktien Opiant Pharmaceuticals, Inc. (OPNT). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

Opiant Pharmaceuticals, Inc. Overview. Opiant Pharmaceuticals, Inc. filed as a Foreign Business Corporation in the State of New York on Friday, March 28, 2014 and is approximately six years old, as recorded in documents filed with New York Department of State. Opiant Pharmaceuticals In early 2017, Skolnick re-retired from NIH to serve as Chief Scientific Officer of Opiant Pharmaceuticals, Inc.—manufacturers of the Narcan nasal spray device.

Dalabergsskolan mat
levi jeans for men

Indication Program / Regulatory Pathway Preclinical Phase I Phase II Phase III NDA FDA Approval Partner; Opioid Overdose: NARCAN® Nasal Spray: Approved: Opioid Overdose

Köp aktien Opiant Pharmaceuticals, Inc. (OPNT). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Opiant Pharmaceuticals currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OPNT will outperform the market and that investors should add to their positions of Opiant Pharmaceuticals. View the latest ratings for OPNT.

About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose. The National Institute on Drug Abuse, a component of the NIH, describes addictive disorders as chronic relapsing brain diseases which burden society at both the individual and community levels.

The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. Stay up to date with news on Opiant is a specialty pharmaceutical company developing medicines for addiction and drug overdose. We conceived and developed the first FDA-approved, user-friendly nasal naloxone spray to reverse an opioid overdose. Opiant is a specialty pharmaceutical company developing medicines for addiction and drug overdose.

Opiant Pharmaceuticals net income from 2014 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for. Enjoy the benefits at Opiant. Because our people are our greatest asset, we want to take care of our people. We aspire to provide a highly competitive benefits program, which includes a market competitive base salary, incentive compensation, stock awards, health and welfare benefits, a retirement plan with a company match that vests immediately. Opiant Pharmaceuticals Announces First Subjects Dosed in Study Comparing OPNT003, Nasal Nalmefene, With Nasal Naloxone.